ESC 365 - The clinical experience of J valve transapical transcatheter aortic valve replacement system in high-risk patients with severe pure aortic regurgitation

ESC Premium Access

The clinical experience of J valve transapical transcatheter aortic valve replacement system in high-risk patients with severe pure aortic regurgitation

Session: Poster Session 2 - Non-coronary cardiac intervention

Topic: Aortic Valve Intervention

Speaker: Mr W. Liu (Beijing, CN)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Mr Wei Liu

Beijing Jishuitan Hospital, Beijing (China)

0 follower

6 more presentations in this session

Comparative evaluation of risk model performance for prediction of 30-day mortality in transcatheter aortic valve replacement

Speaker: Mr G. Wolff (Ibbenbüren, DE)

Clinical implications of physical function and resilience in patients undergoing transcatheter aortic valve implantation

Speaker: Doctor B. Lindman (Nashville, US)

Multiple and posterior location of moderate paravalvular leaks are associated with worse long-term outcome after successful TAVR

Speaker: Doctor L. Kalinczuk (Warsaw, PL)

Percutaneous mitral edge-to-edge valvuloplasty in end-stage heart failure as a bridge to heart transplant: a case series from a single tertiary referral center.

Speaker: Doctor C. Montalto (Milan, IT)

Risk calculator for prediction of iatrogenic atrial septal defect persistence following percutaneous mitral valve repair

Speaker: Doctor O. Maier (Duesseldorf, DE)

Access the full session

Poster Session 2 - Non-coronary cardiac intervention

Speakers: Mr W. Liu, Mr G. Wolff, Doctor B. Lindman, Doctor L. Kalinczuk, Doctor C. Montalto...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources